Multivalent antihelminthic vaccine
A multivalent anthelmintic vaccine targets both hookworm and schistosomiasis. The vaccine includes, at a minimum, a recombinant third-stage larval hookworm antigen, a recombinant adult stage hookworm antigen, and a recombinant schistosome antigen. Preferably, the hookworm antigens are Necator americanus antigens, although antigens from other hookworm species (e.g. Ancylostoma duodenale ) may also be employed. The schistosome antigen is preferably a Schistosoma mansoni or a Schistosoma haematobium antigen although antigens from other schistosome species (e.g. Schistosoma japonicum ) may also be employed. In some cases full or partial sequences of schistosome antigens may be fused with full or partial sequences of hookworm { Necator americanus ) to produce recombinant chimeric antigens.
1. A fusion protein including at least one amino acid sequence selected from the group consisting of SEQ ID NO:32, SEQ ID NO:34, and SEQ ID NO:36.
2. The fusion protein as recited in claim 1 , having the protein sequences of SEQ ID NO: 32.
3. The fusion protein as recited in claim 1 , having the protein sequences of SEQ ID NO: 34.
4. The fusion protein as recited in claim 1 , having the protein sequences of SEQ ID NO: 36.